| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,005 | 0,006 | 22.05. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Verici Dx PLC - Holding(s) in Company | - | RNS | ||
| Di | IN BRIEF: Verici Dx says study validates PTRA in kidney transplants | 2 | Alliance News | ||
| Di | Verici Dx study on kidney transplant rejection test published | 1 | Investing.com | ||
| Di | Verici Dx PLC - Clinical study validating PTRA test published | - | RNS | ||
| 13.05. | Verici Dx PLC - Holding(s) in Company | - | RNS | ||
| VERICI DX Aktie jetzt für 0€ handeln | |||||
| 11.05. | Verici Dx PLC - Holding(s) in Company | - | RNS | ||
| 30.04. | Verici Dx PLC - Holding(s) in Company | - | RNS | ||
| 24.04. | Verici Dx PLC - Holding(s) in Company | - | RNS | ||
| 16.04. | Verici Dx PLC - Positive Q1 Trading Update | - | RNS | ||
| 10.04. | Verici Dx PLC - Holding(s) in Company | - | RNS | ||
| 07.04. | Verici Dx PLC - Holding(s) in Company | - | RNS | ||
| 31.03. | Verici Dx PLC - Board Change | - | RNS | ||
| 30.03. | Verici Dx PLC - Holding(s) in Company | 1 | RNS | ||
| 05.02. | Verici Dx reports $3.8m revenue for FY25, driven by Tutivia test sales | 2 | Investing.com | ||
| 05.02. | Verici Dx PLC - FY25 Trading Update | - | RNS | ||
| 05.02. | Verici Dx PLC - Agreement with BCBS of Illinois for Tutivia | - | RNS |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MEDIGENE | 0,037 | +16,35 % | PTA-Adhoc: Medigene AG: Widerruf der Zulassung der Aktien der Medigene AG zum Handel im regulierten Markt | DJ PTA-Adhoc: Medigene AG: Widerruf der Zulassung der Aktien der Medigene AG zum Handel im regulierten Markt
Veröffentlichung von Insiderinformationen gemäß Artikel 17 MAR Schlagwort(e): Sonstiges... ► Artikel lesen | |
| CO.DON | 0,014 | -20,59 % | EQS-AFR: CO.DON AG i.l.: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: CO.DON AG i.l.
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
CO.DON AG i.l.: Vorabbekanntmachung über die... ► Artikel lesen | |
| SIRONA BIOCHEM | 0,037 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 24.04.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 24.04.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 24.04.2026.ISIN NameCA46658Y1034 J2... ► Artikel lesen | |
| TME PHARMA | 0,082 | -2,84 % | TME Pharma NV: TME PHARMA ANNOUNCES CONVOCATION OF THE 2026 ANNUAL GENERAL MEETING OF SHAREHOLDERS | ||
| REPLENISH NUTRIENTS | 0,071 | 0,00 % | Replenish Nutrients Holding GAAP EPS of -$0.03, revenue of $2.96M | ||
| GLOW LIFETECH | 0,028 | +1,85 % | Glow Lifetech Corp.: Glow Lifetech Expands Distribution with Two of Canada's Largest Cannabis Retailers, Launches New Product Innovation and Advances National Growth Strategy | Toronto, Ontario--(Newsfile Corp. - April 30, 2026) - Glow Lifetech Corp. (CSE: GLOW) (OTCID: GLWLF) (FSE: 9DO) ("Glow" or the "Company") is pleased to provide a commercial update highlighting continued... ► Artikel lesen | |
| NEOVACS | 0,000 | 0,00 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 06.05.2026 | Das Instrument POH3 US14365C1036 CARNIVAL PLC ADR/1 DL1,66 EQUITY wird cum Kapitalmassnahme gehandelt am 06.05.2026 und ex Kapitalmassnahme am 07.05.2026 The instrument POH3 US14365C1036 CARNIVAL PLC... ► Artikel lesen | |
| BIOVAXYS TECHNOLOGY | 0,044 | -100,00 % | CSE Bulletin: Suspensions - VSBLTY Groupe Technologies Corp., NuRAN Wireless Inc., GOAT Industries Ltd., BYT Holdings Ltd., ASEP Medical Holdings Inc., BioVaxys Technology Corp. | Le 6 mai/May 2026
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading... ► Artikel lesen | |
| NANOSPHERE HEALTH SCIENCES | 0,002 | 0,00 % | Nanosphere Health Sciences Inc (2): Nanosphere Health adopts semi-annual reporting | ||
| TELO GENOMICS | 0,033 | -8,33 % | Telo Genomics Corp.: Telo Genomics Announces Study with University of Athens to Advance Next-Generation MRD Risk Stratification in Multiple Myeloma | Vancouver, British Columbia--(Newsfile Corp. - April 14, 2026) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics"), a leader in the development of diagnostic and... ► Artikel lesen | |
| ALTERITY THERAPEUTICS | 0,005 | 0,00 % | ALTERITY THERAPEUTICS LIMITED: Alterity Therapeutics Data Presentations Support Advancement of ATH434 into Phase 3 in Multiple System Atrophy | ||
| MEDMIRA | 0,030 | 0,00 % | MedMira, Inc.: MedMira Reports Second Quarter Results FY2025 | HALIFAX, NS / ACCESS Newswire / April 1, 2026 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended January 31, 2026.Corporate updateIn Q2 FY2026, the Company... ► Artikel lesen | |
| GENETIC TECHNOLOGIES | 0,034 | -100,00 % | GENETIC TECHNOLOGIES LIMITED: Long Term Suspended Entities | ||
| BIOPHYTIS | 0,019 | +2,19 % | BIOPHYTIS: Biophytis participates in the first Longevity Summit | ||
| ACTIVE BIOTECH | 0,006 | -1,56 % | Active Biotech AB: Annual General Meeting of Active Biotech AB | The Annual General Meeting of Active Biotech was held on May 20, 2026. The following main resolutions were passed.In accordance with the Board of Directors' proposal, it was resolved that no dividend... ► Artikel lesen |